Showing 501 - 520 results of 609 for search '(( 20 10 decrease ) OR ( 10 ((meer decrease) OR (((nn decrease) OR (mean decrease)))) ))*', query time: 0.21s Refine Results
  1. 501
  2. 502
  3. 503

    In patients with Chronic Heart Failure Which Polypharmacy Pheno-groups are associated with adverse health outcomes? (Polypharmacy Pheno-groups and Heart failure outcomes) by Mohammed Ibn-Mas'ud, Danjuma

    Published 2023
    “…The median (IQR) age-adjusted Charlson Comorbidity Index (CCI) was 21 – 5. A total of 1475 (20%) participants died within the study period. …”
    Get full text
    Get full text
    Get full text
  4. 504
  5. 505
  6. 506

    Comparing Methods for Induction of Insulin Resistance in Mouse 3T3-L1 Cells. by Al-Jaber, Hend

    Published 2024
    “…TNFα reduced cell proliferation by 10-20%, and chronic TNFα treatment significantly decreased mature adipocytes due to its cytotoxicity. …”
    Get full text
    Get full text
  7. 507
  8. 508
  9. 509
  10. 510
  11. 511
  12. 512
  13. 513
  14. 514

    Proliposome tablets manufactured using a slurry-driven lipid-enriched powders: Development, characterization and stability evaluation by Khan I.

    Published 2018
    “…Proliposome powders were prepared via a slurry method using sorbitol or D-mannitol as carbohydrate carriers in 1:10 or 1:15 w/w lipid phase to carrier ratios. Soya phosphatidylcholine (SPC) and cholesterol were employed as a lipid phase and Beclometasone dipropionate (BDP) was incorporated as a model drug. …”
    Get full text
    Get full text
  15. 515
  16. 516
  17. 517
  18. 518
  19. 519
  20. 520